Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Mouse Monoclonal [clone 2F10] (IgG1,k) to Human SPP1 / Osteopontin
Western blot, ELISA
Mouse Monoclonal [clone 87-B] (IgG2a,k) to Human SPP1 / Osteopontin
Human SPP1 / Osteopontin
Human (tested or 100% immunogen sequence identity)
IgG2a,k Monoclonal [87-B]
Protein G purified
Specificity and Use
Recombinant GST tagged human osteopontin.
Recognizes full length human OPN and C-terminal portion of thrombin cleaved human OPN. Does not react with mouse or bovine OPN
ELISA. Western blot. Immunohistochemistry (Formalin/paraffin) Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM citrate, pH 6.0 for 10 min followed by cooling at RT for 20 min.
PBS buffer, pH 7.2 with 0.09% Sodium Azide
Store at -20°C. Aliquot to avoid freeze/thaw cycles.
SPP1 Antibody, BSPI Antibody, BNSP Antibody, Bone sialoprotein 1 Antibody, ETA-1 Antibody, Nephropontin Antibody, OPN Antibody, Secreted phosphoprotein 1 Antibody, SPP-1 Antibody, SPP1/CALPHA1 fusion Antibody, Urinary stone protein Antibody, Uropontin Antibody, Osteopontin Antibody, Bone sialoprotein I Antibody
Binds tightly to hydroxyapatite. Appears to form an integral part of the mineralized matrix. Probably important to cell-matrix interaction.Acts as a cytokine involved in enhancing production of interferon-gamma and interleukin-12 and reducing production of interleukin-10 and is essential in the pathway that leads to type I immunity.